Jba Joint Revive Capsule
NDC Package 13411-856-15
Package Information
Jba Joint Revive (glucosamine sulfate potassium chloride, white willow bark extract, eggshell membrane collagen, chondroitin sulfate, turmeric root extract, bromelain, soy lecithin) capsules is a human otc drug administered via oral route. This formulation utilizes a capsule delivery system. Marketed by Advanced Pharmaceutical Services, Inc. Dba Affordable Quality Pharmaceuticals, this product is identified by NDC 13411-856.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 13411 - Advanced Pharmaceutical Services, Inc. Dba Affordable Quality Pharmaceuticals
- 13411-856 - Jba Joint Revive
- 13411-856-15 - 15 CAPSULE in 1 BOTTLE
- 13411-856 - Jba Joint Revive
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (13411-856). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 13411-856-15 identifies a specific commercial package of 15 capsule in 1 bottle of Jba Joint Revive, a human over the counter drug labeled by Advanced Pharmaceutical Services, Inc. Dba Affordable Quality Pharmaceuticals. This capsule is formulated for oral use and contains chondroitin sulfate (bovine); egg shell membrane; glucosamine sulfate potassium chloride; salix alba bark; soybean lecithin; stem bromelain; turmeric as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Advanced Pharmaceutical Services, Inc. Dba Affordable Quality Pharmaceuticals on August 13, 2024. The current certification is valid through December 31, 2026.
How is this Advanced Pharmaceutical Services, Inc. Dba Affordable Quality Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 13411085615. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.